MAR 16, 2020 2:39 PM PDT

Cannabis Reduces ADHD Med Use in New Study

WRITTEN BY: Julia Travers

As the legalization of medical cannabis increases in the U.S. and around the globe, its effects on a variety of conditions and behaviors are under examination. In Israel, medical marijuana was first approved for cancer patients, those with chronic pain, and others in the 90s. Use has since expanded, with tens of thousands of people registered as users and Israel's Ministry of Health funding related research. The Evelyn Gruss Lipper Charitable Foundation also funds studies in this area and recently backed an exploration of how medical cannabis use affected the prescription drug intake of Israeli ADHD patients. 

In the U.S., it is estimated that about 6.1 million children have been diagnosed with ADHD to date. ADHD symptoms “start in early childhood and continue into adulthood. In some cases, ADHD is not recognized or diagnosed until the person is an adult,” according to the Mayo Clinic

The recent study focused on 53 Israeli medical cannabis patients who had an ADHD diagnosis. Most had previously gotten the cannabis licenses in relation to chronic pain or cancer treatment. Participants who used medical marijuana were found to use fewer prescription drugs or to stop taking ADHD medications altogether. 

Cannabis consumers were divided into high- and low-dose groups and 27 different combinations of cultivar varieties were trialed. “The cannabinoids most associated with reduced or eliminated ADHD medication use” included CBN, THC, THCV and CBD, Marijuana Moment reported. 

“These findings reveal that the higher-dose consumption of MC components (phyto-cannabinoids and terpenes) is associated with ADHD medication reduction… However, more studies are needed in order to fully understand if cannabis and its constituents can be used for management of ADHD,” the authors concluded. Jeffrey Y. Hergenrather, Joshua Aviram, Yelena Vysotski, Salvatore Campisi-Pinto, Gil M. Lewitus and David Meiri conducted the research. “Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients,” was published in the Rambam Maimonides Medical Journal in January 2020.

Article Sources:

Rambam Maimonides Medical Journal

Marijuana Moment

Mayo Clinic

 

About the Author
  • Julia Travers is a writer, artist and teacher. She frequently covers science, tech, conservation and the arts. She enjoys solutions journalism. Find more of her work at jtravers.journoportfolio.com.
You May Also Like
JUL 13, 2020
Cannabis Sciences
Cannabis Briefly Alleviates PTSD Symptoms
JUL 13, 2020
Cannabis Briefly Alleviates PTSD Symptoms
Therapy is the primary recommended treatment for individuals with post-traumatic stress disorder (PTSD), but a new study ...
SEP 16, 2020
Health & Medicine
72% of Canadian Cannabis Users Say They Don't Fit Stoner Stereotype
SEP 16, 2020
72% of Canadian Cannabis Users Say They Don't Fit Stoner Stereotype
    Nearly three-quarters  (72 percent) of  cannabis users simply don’t see themselves as fitt ...
SEP 27, 2020
Cannabis Sciences
THC Shows Promise in Treating Severe Cases of COVID-19
SEP 27, 2020
THC Shows Promise in Treating Severe Cases of COVID-19
Over the last few months, various headlines have emerged suggesting the potential for cannabinoids, and in particular, c ...
NOV 14, 2020
Cannabis Sciences
New Genetic Test Identifies Cannabis THC Levels from Seeds
NOV 14, 2020
New Genetic Test Identifies Cannabis THC Levels from Seeds
Researchers from the University of Minnesota have developed a genetic test that can predict how much cannabidiol (CBD) o ...
NOV 22, 2020
Cannabis Sciences
Synthetic Cannabinoids Linked to Increased Deaths in Older Patients with COPD
NOV 22, 2020
Synthetic Cannabinoids Linked to Increased Deaths in Older Patients with COPD
Researchers from St. Michael’s Hospital in Toronto have found that two synthetic cannabinoids available on prescri ...
DEC 03, 2020
Cannabis Sciences
Ozone Reacts with THC in Thirdhand Cannabis Smoke
DEC 03, 2020
Ozone Reacts with THC in Thirdhand Cannabis Smoke
Researchers from the University of Toronto have found that ozone, a component of outdoor and indoor air, reacts with tet ...
Loading Comments...